Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicinal use of phyllanthus emblica extract

A technology of emblica and extract, applied in the application field of medicine, can solve the problems of less research and utilization

Active Publication Date: 2015-04-29
CATCH BIO SCI & TECH
View PDF2 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, there is very little research and utilization of Amla emblica in the treatment of hyperuricemia and gout. Chinese patent document CN102441081A discloses a medicine for treating gout and a preparation method thereof, which is a compound composition containing fourteen medicinal materials. , emblica is one of the medicinal materials that is not a monarch drug, and the composition of the medicinal materials is only pulverized, and does not involve the extraction of any possible active ingredients or active parts

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicinal use of phyllanthus emblica extract
  • Medicinal use of phyllanthus emblica extract
  • Medicinal use of phyllanthus emblica extract

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0021] The preparation of embodiment 1 emblica extract

[0022] Get 2000g Amla emblica (purchased from Bozhou Medicinal Materials Market), after pulverization, soak with 16L of 70v% ethanol at room temperature for 24h, then reflux extraction at 20°C for 60min, filter the extract, add 12L of 70v% ethanol to the filter residue, Reflux extraction for 40 minutes, filter, combine the two extracts to obtain the extract of Amla emblica, concentrate to dryness in vacuum to obtain 700g crude extract of Amla emblica (coded as PEE-1), with a yield of 35%.

Embodiment 2

[0023] The preparation of embodiment 2 emblica extract

[0024] Take 2000g Amla emblica (purchased from Bozhou medicinal materials market), crush it, soak it in 16L of water at room temperature for 24h, extract at 80°C for 40min, filter the extract, add 12L of water to the filter residue, and extract at 80°C for 40min , filtered, and combined the two extracts to obtain the extract of Amla emblica, which was concentrated to dryness in vacuum to obtain 900g of extract of Amla emblica (coded as PEE-2), with a yield of 45%.

Embodiment 3

[0025] The preparation of embodiment 3 emblica extract

[0026] The extract of Amla emblica was prepared by the same method as in Example 1, and 200 g of the crude extract of Amla emblica was taken, dissolved in water, and chromatographically performed with D101 macroporous adsorption resin. The mass ratio of extract to resin is 1:20. Gradient elution was performed with water, 50v% ethanol, and 95v% ethanol in sequence, each gradient eluted with 4 times the column volume, and the flow rate was 3 times the column volume / hour. After the elution is completed, the water eluate, the 50v% ethanol eluate, and the 95v% ethanol eluate are concentrated to dryness to obtain a refined and purified emblica extract.

[0027] Among them, 102g of refined and purified emblica extract (coded as PEW) was obtained from the water elution part, 72g of refined and purified emblical extract (coded as PE50) was obtained from the 50v% ethanol elution part, and 95v% ethanol elution part A total of 13 ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medicinal use of phyllanthus emblica extract and particularly relates to application of the phyllanthus emblica extract to preparing a drug for treating hyperuricemia. The phyllanthus emblica has an effect of treating the hyperuricemia, can be used for effectively lowering uric acid content in blood and can achieve good curative effects of treating hyperuricemia-associated metabolic diseases of acute gout, chronic gout, gouty arthritis, gout flare, uratic renal lithiasis, gouty nephropathy and the like.

Description

technical field [0001] The invention relates to a new indication of Amlican emblica, in particular to the application of the extract of Amlican emblica in the preparation of medicine for treating hyperuricemia. Background technique [0002] In the field of chemical medicine, uric acid is the terminal metabolite of human purine compounds. Disorders of purine metabolism lead to hyperuricemia. Under a normal purine diet, if the blood uric acid level on an empty stomach is higher than 420 μmol / L for men and 360 μmol / L for women on two different days, it is called hyperuricemia. The prevalence of this disease is affected by many factors, related to heredity, sex, age, lifestyle, eating habits, drug treatment and economic development. According to reports on the prevalence of hyperuricemia in various places in recent years, there are currently about 120 million hyperuricemia patients in my country, accounting for about 10% of the total population. trend. With the change of peop...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/47A61P19/06A61P19/02A61P13/12
Inventor 温尧林夏增华贾远敏张新新
Owner CATCH BIO SCI & TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com